High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2493-2498

  Vairaktaris, Eleftherios ^a   Serefoglou, Zoe ^a   Yapijakis, Christos ^a   Vylliotis, Antonis ^a   Nkenke, Emeka ^b   Derka, Spyridoula ^a   Vassiliou, Stavros ^a   Avgoustidis, Dimitrios ^a   Neukam, Friedrich W ^b   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Matrix metalloproteinase 7; MMP 7; Oral cancer; Polymorphism; Tumor invasion

Indexed keywords

MATRILYSIN;

ADULT; AGED; ALLELE; ANGIOGENESIS; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC RISK; GERMANY; GREECE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; SEX RATIO; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34547815201     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Silverman S Jr: Demographics and occurrence of oral and pharyngeal cancers.The outcomes, the trends, the challenge. J Am Dent Assoc 132: 75-115, 2001.
2. Williams HK: Molecular pathogenesis of oral carcinoma. J Clin Pathol 53: 165-172, 2000.
3. Tsai MH, Chen WC, Chen HY and Tsai FJ: Urokinase gene 3′-UTR T/C polymorphism is associated with oral cancer. J Clin Lab Anal 18: 276-279, 2004.
4. Watanabe H, Iwase M, Ohashi M and Nagumo M: Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncol 38: 670-679, 2002.
5. Vairaktaris E, Yapijakis C, Wiltfang J, Ries J, Vylliotis A, Vassiliou S and Neukman FW: Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res 25: 2561-2566, 2005.
6. Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Vairaktaris E, Yapijakis C, Vylliotis A Wiltfang J, Kessler P, Ries J, Vassiliou S, Derka S and Neukman FW: Methylene-tetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132: 219-222, 2006.
7. Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P and Neukman FW: Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42: 888-892, 2006.
8. Vairaktaris E, Yapijakis C, Derka S, Serefoglou Z, Vassiliou S, Nkenke E, Ragos V, Vylliotis A, Spyridonidou S, Tsigris C, Yannopoulos A, Tesseromatis C, Neukam FW and Patsouris E: Association of matrix metalloproteinase-1 (-1607 1G/2G) Polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res 27: 459-464, 2007.
9. Vairaktaris E, Yiannopoulos A, Vylliotis A, Yapijakis C, Derka S, Vassiliou S, Nkenke E, Serefoglou Z, Ragos V, Papageorgiou G, Vorris E, Critselis E, Avgoustidis D, Neukam FW and Patsouris E: Strong association of interleukin-6-174G>C promoter polymorphism with increased risk for oral cancer. Int J Biol Markers 21: 246-250, 2006.
10. Vairaktaris E, Yapijakis C, Serefoglou Z, Derka S, Vassiliou S, Nkenke E, Vylliotis A, Wiltfang J, Avgoustidis D, Critselis E, Patsouris E and Neukam FW: The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 33: 504-507, 2006.
11. Shiomi T and Okada Y: MT 1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 22(2-3): 145-152, 2003.
12. So J, Navari J, Wang FQ and Fishman DA: Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8. Gynecol Oncol 95: 314-322, 2004.
13. Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K and Saarialho-Kere U: Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202: 14-22, 2004.
14. Westermarck J and Kähäri VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
15. Fontaine V, Jacob MP, Houard X, Rossianol P, Plissonnier D, Agles-Cano E and Michel JB: Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161: 1701-1709, 2002.
16. Kerkela E and Saarialho-Kere U: Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12: 109-125, 2003.
17. Ii M, Yamamoto H, Adachi Y, Maruyama Y and Shinomura Y: Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231: 20-27, 2006.
18. Sang QX: Complex role of matrix metalloproteinase in angiogenesis. Cell Res 8: 171-177, 1998.
19. Wilson CL and Matrisian LM: Matrilysin an epithelial matrix metalloproteinase with potentially novel functions. Int J BiochemCell Biol 28: 123-136, 1996.
20. Werner JA, Rathcke IO and Mandic R: The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 19: 275-282, 2002.
21. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B, Stamp G, Baron A, Scarpa A and Lemoine NR: Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21: 4587-4594, 2002.
22. Piura B, RAbinovich A and Huleihel M: Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract. Harefuah 142: 786-791,804, 2003.
23. Ogawa M, Ikeuchi K, Watanabe M, Etoh K, Kobayashi T, Takao Y and Yamazaki Y: Expression of matrix metalloproteinase 7, lamini and type IV collagene-associated liver metastasis in human colorectal cancer: immunohistochemical approach. Hepatogastroenterol 52: 875-880, 2005.
24. Voorzanger-Rousselot N, Juillet F, Mareau E, Zimmermann J Kalebic T and Garnero P: Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation. Br J Cancer 95: 506-514, 2006.
25. Lee KH, Shin SJ, Kin KO, Kim MK, Hyun MS, Kim TN, Jang BI, Kim SW, Song SK, Kim HS, Bae SH and Ryoo HM: Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol Rep 16: 823-830, 2006.
26. Soreide K, Janssen EA, Korner H and Baak JP: Trypsin in colorectal cancer: molecular biological mechanisms of proliferation invasion and metastasis. J Pathol 209: 147-156, 2006.
27. Fingleton BM, Heppner Goss K, Crawford HC and Matrisian LM: Matrilysin in early stage intestinal tumorigenesis. Acta Pathol Micr Immunol Sc 107: 102-110, 1999.
28. Patterson BC and Sang QXA: angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/Type IV collogenase (MMP-9). J Biol Chem 272: 28823-28825, 1997.
29. Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A and Eriksson P: Allele specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21: 1834-1839, 2001.
30. Ghilardi G, Biondi ML, Erario M, Guagnellini E and Scorza R: Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem 49: 1940-1942, 2003.
31. Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, Guo W, Wang Y, Wen D, Wei L, Dong Z and Kuang G: The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26: 1748-1753, 2005.
32. Li Y, Jin S, Wang Y, Du H, Zhang J, Guo W, Wang N and Fang S: Polymorphisms in the promoter regions of the matrix metalloproteinases-1,-3,-7 and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol 101: 92-96, 2006.
33. Lu Z, Wang Y, Zhang Q, Zhang X, Wang S, Xie H, Li Y, Jiao B and Zhang J: Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma. Brain Res 1118: 6-12, 2006.
34. Kubben FJGM, Sier CFM, Meijer MJW, Berg M, Reijden JJ, Griffioen G, Velde CJH, Lamers CBHW and Verspaget HW: Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 95: 744-751, 2006.
35. Shan K, Lian-Fu Z, Hui D, Wei G, Na W, Xia J and Yan L: Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China. Mol Hum Reprod 12: 35-39, 2006.
36. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y and Imai K: Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45: 252-258, 1999.
37. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N and Okada Y: Matrix metalloproteinase 7 (Matrilysin) from human rectal carcinoma cells. J Biol Chem 270(12): 6691-6697, 1995.
38. Yapijakis C, Vairaktaris E, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Vassiliou S, Avgoustidis D, Neukam FW and Patsouris E: Association of polymorphisms affecting gene expression of tumor necrosis factor alpha and beta with increased risk for oral cancer. Int J Biol Markers, in press, 2007.
39. Vairaktaris E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C, Vylliotis A, Yapijakis C, Neukam FW and Patsouris E: A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol, in press, 2007.
40. Jin X, Kuang G, Wei LZ, Li Y, Wang R, Guo W, Wang N, Fang SM, Wen DG, Chen ZF and Zhang JH: No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J Gastroenterol 11: 2385-2389, 2005.
41. Cao ZG and Li CZ: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 42: 32-38, 2006.